Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Patient-Reported Outcomes in Systemic Lupus Erythematosus. Can Lupus Patients Take the Driver’s Seat in Their Disease Monitoring?
Ioannis Parodis, Paul Studenic
Journal of Clinical Medicine (2022) Vol. 11, Iss. 2, pp. 340-340
Open Access | Times Cited: 16

Showing 16 citing articles:

Holistic approaches in systemic lupus erythematosus: do physicians avoid addressing difficult-to-treat but highly relevant symptoms?
Ioannis Parodis, Chris Wincup, Zahi Touma, et al.
RMD Open (2025) Vol. 11, Iss. 1, pp. e005400-e005400
Open Access
Patients with NPSLE experience poorer HRQoL and more fatigue than SLE patients with no neuropsychiatric involvement, irrespective of neuropsychiatric activity
Dionysis Nikolopoulos, Nurşen Çetrez, Julius Lindblom, et al.
Lara D. Veeken (2024) Vol. 63, Iss. 9, pp. 2494-2502
Open Access | Times Cited: 4
How Can We Enhance Adherence to Medications in Patients with Systemic Lupus Erythematosus? Results from a Qualitative Study
Sharzad Emamikia, Cidem Gentline, Yvonne Enman, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 7, pp. 1857-1857
Open Access | Times Cited: 20
Do biological agents improve health-related quality of life in patients with systemic lupus erythematosus? Results from a systematic search of the literature
Alvaro Gómez, Ioannis Parodis
Autoimmunity Reviews (2022) Vol. 21, Iss. 11, pp. 103188-103188
Open Access | Times Cited: 17
Impact of Belimumab on Patient-Reported Outcomes in Systemic Lupus Erythematosus: Insights from Clinical Trials and Real-World Evidence
Alvaro Gómez, Yvonne Enman, Ioannis Parodis
Patient Related Outcome Measures (2023) Vol. Volume 14, pp. 1-13
Open Access | Times Cited: 8
Reframing health disparities in SLE: A critical reassessment of racial and ethnic differences in lupus disease outcomes
Ioannis Parodis, Cristina Lanata, Dionysis Nikolopoulos, et al.
Best Practice & Research Clinical Rheumatology (2023) Vol. 37, Iss. 4, pp. 101894-101894
Open Access | Times Cited: 8
EQ-5D full health state after therapy heralds reduced hazard to accrue subsequent organ damage in systemic lupus erythematosus
Julius Lindblom, Sture Zetterberg, Sharzad Emamikia, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 9
Development of the American College of Rheumatology Patient‐Reported Outcome Quality Measures for Systemic Lupus Erythematosus
Patricia Katz, Claire E.H. Barber, Alí Duarte‐García, et al.
Arthritis Care & Research (2024) Vol. 76, Iss. 6, pp. 777-787
Closed Access | Times Cited: 1
Evolving Concepts in Treat-to-Target Strategies for Systemic Lupus Erythematosus
Dionysis Nikolopoulos, Maria Helena Lourenço, Roberto Depascale, et al.
Mediterranean Journal of Rheumatology (2024) Vol. 35, Iss. Suppl 2, pp. 328-328
Open Access | Times Cited: 1
Patient-reported outcome measures for systemic lupus erythematosus: an expert Delphi consensus to guide implementation in routine care
Isabel Castrejón, Laura Cano, María J. Cuadrado, et al.
BMC Rheumatology (2024) Vol. 8, Iss. 1
Open Access | Times Cited: 1
Opportunities and challenges of lupus care in Latin America, the Middle East, and Asia-Pacific: A call to action
Eduardo Mysler, Odirlei André Monticielo, Ibrahim A. Al-Homood, et al.
Modern Rheumatology (2024) Vol. 34, Iss. 4, pp. 655-669
Open Access
Trajectories of disease evolution upon treatment initiation in systemic lupus erythematosus: results from four clinical trials of belimumab
Ioannis Parodis, Julius Lindblom, Alexander Tsoi, et al.
Lara D. Veeken (2024)
Open Access
Patient-reported outcomes with anifrolumab in patients with systemic lupus erythematosus
Tanja Stamm, Ioannis Parodis, Paul Studenic
The Lancet Rheumatology (2022) Vol. 4, Iss. 3, pp. e157-e159
Closed Access | Times Cited: 3
Evaluating the real-world effectiveness of belimumab in patients with SLE using SLE-related laboratory values and rheumatoid arthritis-derived disease activity measures: RAPID3, swollen joint count and tender joint count
Guillaume Germain, Karen Worley, Sean D. MacKnight, et al.
Lupus Science & Medicine (2024) Vol. 11, Iss. 1, pp. e001111-e001111
Open Access
Performance of a New Instrument for the Measurement of Systemic Lupus Erythematosus Disease Activity: The SLE-DAS
Malcolm Koo, Ming‐Chi Lu
Medicina (2023) Vol. 59, Iss. 12, pp. 2097-2097
Open Access | Times Cited: 1
Adherence patterns to medications and their association with subsequent hospitalization in adult Egyptian patients with systemic lupus erythematosus
Samar Tharwat, Eman Ali Shaker
Lupus (2023) Vol. 32, Iss. 11, pp. 1335-1344
Closed Access
Page 1

Scroll to top